A Message from CEO, Martin Rosendale: Working for our Maryland Life Science members at the 2020 Biotech Showcase

Dear Member,

We just spent an incredible week in San Francisco at the Biotech Showcase and JP Morgan Healthcare Conference! The quality of the meetings and interactions were remarkable. We were working on behalf of our Maryland Life Sciences members – networking, meeting with investors, and sharing your incredible stories.

We attended plenary sessions, luncheons, and pitches to catch up on innovation happening all over the world, and one idea remains strong: Maryland is leading the life sciences industry in gene and cell therapy, immunotherapy, and life-saving vaccines. Our participation at these events this week confirms that we have exactly what it takes to be the number one life sciences hub in the nation, and I am proud to be part of the journey.

Estimates suggest over 35,000 executives were in the city for the JP Morgan Healthcare Conference, and 3,700 people registered for the Biotech Showcase. There were 412 Partner Presentations at the Biotech Showcase, 70,000 meeting requests, and 8,000 scheduled meetings with 1,000 vetted investors. All in all, it was the perfect place for us to host and offer private meeting space for our members to meet with investors and partners. Our members in attendance utilized the complimentary space with a total of 58 meetings scheduled over 3 days. We extend a special thank you to Montgomery County Economic Development Corporation for sponsoring our meeting room.

The Biotech Showcase has grown into one of the bio pharma industry’s leading investor conferences. According to Informa Pharma, between 2015 and 2019, companies that have presented at the showcase have gone on to participate in 681 deals, comprising 271 alliance deals with a total potential value of $47 billion, 394 financing deals worth $14 billion (cancer treatments leading the way), and 29 company acquisitions at a total value of $7.9 billion. Deals are happening here; we will be back again next year to offer space and make it easier for you to do business when you’re here alongside us.

Connections are made because of relationships, and we have been expanding those relationships this week. We were sought out by investors wanting to know about the innovation in Maryland, and we amplified our story. We have four follow-up meetings with investors who are interested in coming to Maryland to meet you and hear your stories. I personally had over 58 meetings this week, which resulted in 30 new connections and four new members joining the MTC family.

It was an honor to have been here this week to represent Maryland’s innovative spirit and raise the profile of our life sciences community. We look forward to attending next year, and we hope you will be with us when we do.

All the best,
Martin Rosendale
Chief Executive Officer
Maryland Tech Council